<DOC>
	<DOCNO>NCT01869049</DOCNO>
	<brief_summary>This project undertake Qilu Hospital Shandong University well-known hospital China . In order report alteration macrophage function spleen tissue primary immune thrombocytopenia ( ITP ) .</brief_summary>
	<brief_title>The Alteration Macrophage Function Spleen Tissues From Patients With Primary Immune Thrombocytopenia</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>adult ITP patient whose platelet count remain less 10 x 10^9/L patient whose platelet count remain less 30 x 10^9/L continue experience excessive bleeding 4 6 week appropriate medical treatment patient experience transient response primary treatment platelet count less 30 x 10^9/L 3 month require continuous glucocorticoid therapy maintain safe platelet count Willing able sign write informed consent . Received chemotherapy anticoagulant drug affect platelet count within 3 month screen visit . Current HIV infection hepatitis B virus hepatitis C virus infection . Severe medical condition ( lung , hepatic renal disorder ) chronic ITP . Unstable uncontrolled disease condition relate impacting cardiac function ( e.g. , unstable angina , congestive heart failure , uncontrolled hypertension cardiac arrhythmia ) Female patient pregnant . Have know diagnosis autoimmune disease , establish medical history laboratory finding positive result determination antinuclear antibody , anticardiolipin antibody , lupus anticoagulant direct Coombs test . Patients deem unsuitable study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Immune Thrombocytopenia</keyword>
	<keyword>macrophage</keyword>
	<keyword>spleen tissue</keyword>
</DOC>